Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales

Cafepharma Today

April 16 2024 - J&J narrowly misses Q1 revenue on lower-than-expected Stelara sales

J&J narrowly misses Q1 revenue on lower-than-expected Stelara sales
Ukraine was pharma’s ‘darling’ of clinical trials. As war drags on, will the industry come back?
Humira biosimilar scripts take off
Intra-Cellular launches 26% to record high, breaking out after depression drug scores big
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Wave of lawsuits follow warnings that top-selling diabetes drug may raise bladder cancer risk

Yahoo/AP

Monday, August 8, 2011 - 12:30pm

tags:

bladder cancer, diabetes, Takeda, Actos

Pozen wins court battle over migraine drug

Bizjournals.com

Monday, August 8, 2011 - 12:27pm

tags:

Par Pharmaceutical, Pozen, migraines, Treximet, generics

Cytokinetics sinks 18% in early trading

Marketwatch

Monday, August 8, 2011 - 11:50am

tags:

Teva Sued by GlaxoSmithKline, Pfizer Venture Over HIV Drug

Bloomberg

Monday, August 8, 2011 - 11:24am

tags:

GSK, Pfizer, Teva Pharmaceuticals, HIV, Epzicom

Insmed, Inc. Earnings Cheat Sheet: Widening Losses Push Company Below Estimates

Yahoo/AP

Monday, August 8, 2011 - 11:23am

tags:

earnings, Insmed

Qiagen: FDA Submissions May Make This Bottom Bouncer More Appealing

Seeking Alpha

Monday, August 8, 2011 - 11:22am

tags:

Qiagen, FDA, Erbitux, cancer

Merck gets subpoena tied to marketing of 3 drugs

Yahoo/AP

Monday, August 8, 2011 - 11:21am

tags:

Merck, Temodar, PegIntron, Intron A, hepatitis C, Schering Plough

Dendreon Wounds Are Self-Inflicted, Not the Start of a Biotech Industry Virus

Motley Fool

Monday, August 8, 2011 - 9:18am

tags:

Dendreon, biotech, Provenge, prostate cancer

Cardiome Reports Second Quarter Results

Yahoo

Monday, August 8, 2011 - 9:17am

tags:

earnings, Cardiome

Teva Receives FDA Acceptance of Its New Drug Application for BDP Nasal HFA for the Treatment of Allergic Rhinitis

Yahoo

Monday, August 8, 2011 - 9:14am

tags:

Teva Pharmaceuticals, FDA, BDP Nasal HFA, allergic rhinitis

Valeant Pharma Beats, Ups View

Yahoo/Zacks.com

Monday, August 8, 2011 - 9:11am

tags:

earnings, Valeant Pharmaceuticals

What is Teva really worth?

Globes, Israel

Sunday, August 7, 2011 - 11:44am

tags:

Teva Pharmaceuticals

Dr Reddy's expects North American biz to drive growth this FY

Economic Times, India

Sunday, August 7, 2011 - 11:43am

tags:

Generic drug industry slams special deal in patent reform bill

The Hill

Sunday, August 7, 2011 - 11:41am

tags:

India's Aurobindo Pharma posts 1Q loss

MarketWatch

Saturday, August 6, 2011 - 1:56pm

tags:

Aurobindo, earnings

Qiagen Completes Second U.S. Submission For Companion Diagnostic To Guide Treatment Decisions In Colorectal Cancer

Biomed Reports

Saturday, August 6, 2011 - 1:53pm

tags:

Qiagen, KRAS assay, Erbitux, colorectal cancer

HHS-OIG Drops Potential Action against Forest CEO Howard Solomon

MarketWatch

Saturday, August 6, 2011 - 1:51pm

tags:

OIG, investigations, legal, Forest Labs

Enzon Inc. Reports Operating Results (10-Q)

GuruFocus

Saturday, August 6, 2011 - 1:29pm

tags:

Enzon, earnings

U.K. rejects MS drug over cost

Yahoo/Investor's Business Daily

Saturday, August 6, 2011 - 1:26pm

tags:

Novartis, multiple sclerosis, Gilenya

Novo Nordisk Revenues Up

Yahoo/Zacks

Saturday, August 6, 2011 - 1:25pm

tags:

Novo Nordisk, earnings

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition

Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research

First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study

Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth

Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Sapio Sciences launches new drug discovery platform

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

How Patient Engagement Can Reduce Brand Launch Risks

Drug Channels

The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead

Drug Channels

SAVE THE DATE: Drug Channels Leadership Forum, March 17-19, 2025

Drug Channels

Tales of the Unsurprised: U.S. Brand-Name Drug Prices Fell for an Unprecedented Sixth Consecutive Year—And Will Fall Further in 2024 (rerun)

Drug Channels

Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies (rerun)

Drug Channels

The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup (rerun)

Drug Channels

What CVS Pharmacy’s New Cost-Plus Reimbursement Approach Means for PBMs, Pharmacies, Plan Sponsors, and Prescription Prices (rerun)

Drug Channels

Understanding CVS Health/McKesson and Why Pharmacies Lose Money on GLP-1s (rerun)

Drug Channels

Navigating Market Access Challenges in Life Sciences Commercialization

Drug Channels